Prospera Financial Services Inc Biogen Inc. Transaction History

Prospera Financial Services Inc

$3.82 Billion
Q3 2024

A detailed history of Prospera Financial Services Inc transactions in Biogen Inc. stock. As of the latest transaction made, Prospera Financial Services Inc holds 1,048 shares of BIIB stock, worth $157,870. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,048

Previous 1,472 28.8%

Holding current value

$157,870

Previous $341,000 40.47%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$189.07 - $236.8 $80,165 - $100,403	-424 Reduced 28.8%	1,048 $203,000
Q2 2024 Aug 13, 2024	SELL	$190.52 - $236.72 $175,087 - $217,545	-919 Reduced 38.44%	1,472 $341,000
Q1 2024 Aug 13, 2024	BUY	$212.02 - $267.71 $66,150 - $83,525	312 Added 21.2%	1,784 $384,000
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $277,792 - $334,389	1,248 Added 109.19%	2,391 $618,000
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $1.47 Million - $1.66 Million	-5,821 Reduced 83.59%	1,143 $293,000
Q2 2023 Aug 08, 2023	BUY	$275.25 - $318.06 $186,619 - $215,644	678 Added 10.79%	6,964 $1.98 Million
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $2,822 - $3,215	11 Added 0.18%	6,286 $1.75 Million
Q4 2022 Feb 08, 2023	BUY	$252.44 - $306.72 $1.58 Million - $1.92 Million	6,275 New	6,275 $1.74 Million
Q2 2022 Aug 08, 2022	SELL	$187.54 - $223.02 $89,456 - $106,380	-477 Reduced 50.74%	463 $94,000
Q1 2022 May 04, 2022	BUY	$193.77 - $244.14 $3,875 - $4,882	20 Added 2.17%	940 $198,000
Q4 2021 Feb 10, 2022	SELL	$223.92 - $287.77 $1.42 Million - $1.83 Million	-6,345 Reduced 87.34%	920 $220,000
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $1.81 Million - $2.36 Million	6,404 Added 743.79%	7,265 $2.06 Million
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $71,225 - $114,045	-275 Reduced 24.21%	861 $298,000
Q1 2021 May 06, 2021	BUY	$242.95 - $284.63 $275,991 - $323,339	1,136 New	1,136 $317,000
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $6,142 - $9,246	-26 Closed	0 $0
Q3 2020 Nov 04, 2020	SELL	$264.77 - $305.71 $196,194 - $226,531	-741 Reduced 96.61%	26 $7,000
Q2 2020 Aug 07, 2020	BUY	$258.66 - $342.55 $198,392 - $262,735	767 New	767 $205,000
Q4 2019 Feb 12, 2020	SELL	$220.06 - $304.07 $583,379 - $806,089	-2,651 Closed	0 $0
Q3 2019 Oct 22, 2019	BUY	$217.44 - $243.88 $576,433 - $646,525	2,651 New	2,651 $617,000
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $389,064 - $492,791	-1,397 Closed	0 $0
Q3 2018 Oct 25, 2018	SELL	$293.51 - $383.83 $74,845 - $97,876	-255 Reduced 15.44%	1,397 $411,000
Q2 2018 Jul 18, 2018	BUY	$257.52 - $306.91 $137,773 - $164,196	535 Added 47.9%	1,652 $483,000
Q1 2018 Apr 12, 2018	SELL	$260.13 - $367.91 $156,598 - $221,481	-602 Reduced 35.02%	1,117 $305,000
Q4 2017 Jan 24, 2018	BUY	$307.64 - $344.58 $310,716 - $348,025	1,010 Added 142.45%	1,719 $563,000
Q3 2017 Oct 11, 2017	BUY	$281.15 - $329.69 $199,335 - $233,750	709	709 $223,000

Others Institutions Holding BIIB

# of Institutions

1,038

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.

Account

Prospera Financial Services Inc Biogen Inc. Transaction History